Evidence map›Paper›PMID 25453328›Full record

ReviewJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2015

Recent advances in research on Crimean-Congo hemorrhagic fever.

Anna Papa, Ali Mirazimi, Iftihar Köksal, Augustin Estrada-Pena, Heinz Feldmann

Open access · greenAbstract readReview
In one paragraph

Review in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Differential Cell Line Susceptibility to Crimean-Congo Hemorrhagic Fever Virus.Frontiers in cellular and infection microbiology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Climatic changes and their role in emergence and re-emergence of diseases.Environmental science and pollution research international · 2020
    Review
  18. Emerging Tick-Borne Diseases.Clinical microbiology reviews · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 5 countries.

Anna PapaDepartment of Microbiology, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: annap@med.auth.gr.
Ali MirazimiSwedish Institute for Communicable Disease Control, SE 171 82 Sweden; National Veterinary Institute, SE-756 51 Sweden; Dept for Clinical and Experimental Medicine, Linkopings University, SE-581 83 Sweden.
Iftihar KöksalKaradeniz Technical University, Medical Faculty, Department of Infectious Diseases, Trabzon, Turkey.
Augustin Estrada-PenaDepartment of Animal Pathology, University of Zaragoza, Zaragoza, Spain.
Heinz FeldmannLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, USA.
Aristotle University of Thessaloniki · GRKaradeniz Technical University · TRLinköping University · SENational Institutes of Health · USUniversidad de Zaragoza · ES

Funding

Viral Hemorrhagic Fevers: Disease Modeling and TransmissionZIAAI001089 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2009 to 2025
$50.7M
Intramural NIH HHS ZIA AI001089
6 · The paper itself

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is an expanding tick-borne hemorrhagic disease with increasing human and animal health impact. Immense knowledge was gained over the past 10 years mainly due to advances in molecular biology, but also driven by an increased global interest in CCHFV as an emerging/re-emerging zoonotic pathogen. In the present article, we discuss the advances in research with focus on CCHF ecology, epidemiology, pathogenesis, diagnostics, prophylaxis and treatment. Despite tremendous achievements, future activities have to concentrate on the development of vaccines and antivirals/therapeutics to combat CCHF. Vector studies need to continue for better public and animal health preparedness and response. We conclude with a roadmap for future research priorities.

Indexed as

AnimalsAntiviral AgentsCommunicable Diseases, EmergingHemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoHumansTicksViral VaccinesZoonosesAntiviral AgentsViral VaccinesCrimean-Congo hemorrhagic feverEcologyEpidemiology

Identifiers

PMID25453328
PMCPMC4346445
OpenAlexW2065584999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.